These findings not only provide evidence that maintaining the homeostasis of tubular Insig1 is a novel mechanism in mediating CKD, but also identify nicardipine as a specific Aldh1a1 antagonist for treating CKD. This evidence concerns the gene INSIG1 and chronic kidney disease.